MRNA EBITDA Growth
Moderna · EBITDA Growth
MRNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-3.89%period ending
MRNA TTM EBITDA YoY % (-43.89% → -3.89%)
Year-over-year change
High-resolution chart · PNG
MRNA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -3.8928% | |
| 9.7027% | |
| 24.8379% | |
| -46.997% | |
| 27.8867% | |
| 23.7106% | |
| -3.3811% | |
| -10.022% | |
| -409.2547% | |
| -177.2694% | |
| -133.0149% | |
| -113.2681% | |
| -92.3568% | |
| -67.2646% | |
| -26.4986% | |
| 75.8983% | |
| 306.0996% | |
| 2,299.2975% | |
| 2,024.5432% | |
| 1,497.8651% | |
| 974.6751% | |
| 247.0157% | |
| -47.0158% | |
| -11.9863% | |
| 1.4571% | |
| -13.2029% | |
| -33.5567% | |
| -90.0467% | |
| -82.2345% | |
| -72.1004% | |
| -43.8881% |